Literature DB >> 24951853

Occasional spontaneous clearance of chronic hepatitis C virus in HIV-infected individuals.

Jenny Stenkvist1, Jessica Nyström2, Karolin Falconer1, Anders Sönnerborg3, Ola Weiland4.   

Abstract

The IL28B genotype has been found to have a strong influence on spontaneous clearance of acute HCV both in HCV mono- and HIV/ the HCV co-infected patients. Spontaneous clearance of chronic HCV without HCV treatment is rare. Here, we report on three chronic HCV cases co-infected with HIV with spontaneous clearance of their HCV infection, all with the IL28B CC genotype. These cases were derived from a surveillance of the total HIV/HCV co-infected cohort in Sweden (n =4 66). The estimated frequency of spontaneous clearance of chronic HCV infection in our cohort was calculated to be 0.6-4.7%. Our cases lend some support to the initiation of ART prior to HCV treatment in HIV/HCV co-infected patients. Furthermore, HCV-RNA testing should be recommended immediately before initiation of HCV treatment, to find the subset of HIV/HCV co-infected patients with IL28B CC that may have cleared their chronic infection spontaneously.
Copyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HCV; HIV; HIV/HCV co-infection; IL28B

Mesh:

Substances:

Year:  2014        PMID: 24951853     DOI: 10.1016/j.jhep.2014.06.014

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.

Authors:  Julia L Marcus; Wendy A Leyden; Chun R Chao; Lanfang Xu; Charles P Quesenberry; Phyllis C Tien; Daniel B Klein; William J Towner; Michael A Horberg; Michael J Silverberg
Journal:  AIDS Patient Care STDS       Date:  2015-05-18       Impact factor: 5.078

2.  Hierarchical assessment of host factors influencing the spontaneous resolution of hepatitis C infection.

Authors:  Paola Jocelan Scarin Provazzi; Livia Maria Gonçalves Rossi; Bruno Moreira Carneiro; Valeria Chamas Miura; Plinio Cesar Rodrigues Rosa; Lucas Rodrigues de Carvalho; Stephane Tereza Queiroz de Andrade; Roberta Maria Fachini; Rejane Maria Tommasini Grotto; Giovanni Faria Silva; Carlos Roberto Valêncio; Paulo Scarpelini Neto; José Antonio Cordeiro; Mauricio Lacerda Nogueira; Paula Rahal
Journal:  Braz J Microbiol       Date:  2018-12-04       Impact factor: 2.476

3.  IL-28B genetic variation, gender, age, jaundice, hepatitis C virus genotype, and hepatitis B virus and HIV co-infection in spontaneous clearance of hepatitis C virus.

Authors:  Sergii V Fedorchenko; Anna Klimenko; Tetyana Martynovich; Olga Liashok; Vitaliy Yanchenko
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

Review 4.  Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.

Authors:  Kara W Chew; Debika Bhattacharya
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

5.  Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis: a case report.

Authors:  Borja Mora-Peris; Robert D Goldin; David Muir; Janice Main; Ricky Gellissen; Anthony Brown; Eleanor Barnes; Graham Cooke
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

6.  A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.

Authors:  Anja De Weggheleire; Sokkab An; Irith De Baetselier; Pisith Soeung; Huy Keath; Veasna So; Sreyphors Ros; Syna Teav; Bart Smekens; Jozefien Buyze; Eric Florence; Johan van Griensven; Sopheak Thai; Sven Francque; Lutgarde Lynen
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

7.  Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy.

Authors:  Mario Frias; Antonio Rivero-Juarez; Francisco Tellez; Monserrat Perez-Perez; Angela Camacho; Isabel Machuca; Sandra Lorenzo-Moncada; Pedro Lopez-Lopez; Antonio Rivero
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.